Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forUGT1A1and Atazanavir Prescribing-Reference-Cited by-同舟云学术

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forUGT1A1and Atazanavir Prescribing

Published:2015-11-09 Issue:4 Volume:99 Page:363-369
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Gammal RS¹,Court MH²,Haidar CE¹,Iwuchukwu OF³⁴,Gaur AH⁵,Alvarellos M⁶,Guillemette C⁷,Lennox JL⁸,Whirl-Carrillo M⁶,Brummel SS⁹,Ratain MJ¹⁰,Klein TE⁶,Schackman BR¹¹,Caudle KE¹,Haas DW¹²

Affiliation:

1. Department of Pharmaceutical Sciences; St. Jude Children's Research Hospital; Memphis Tennessee USA

2. Individualized Medicine Program, Department of Veterinary Clinical Sciences; Washington State University College of Veterinary Medicine; Pullman Washington USA

3. Division of Pharmaceutical Sciences; Fairleigh Dickinson University School of Pharmacy; Florham Park New Jersey USA

4. Division of Clinical Pharmacology, Department of Medicine; Vanderbilt University Medical Center; Nashville Tennessee USA

5. Department of Infectious Diseases; St. Jude Children's Research Hospital; Memphis Tennessee USA

6. Department of Genetics; Stanford University; Stanford California USA

7. Laval University CHU de Québec Research Center; Quebec Quebec Canada

8. Division of Infectious Disease; Emory University School of Medicine; Atlanta Georgia USA

9. Center for Biostatistics in AIDS Research; Harvard T.H. Chan School of Public Health; Boston Massachusetts USA

10. Center for Personalized Therapeutics, Comprehensive Cancer Center; The University of Chicago; Chicago Illinois USA

11. Department of Healthcare Policy and Research; Weill Cornell Medical College; New York New York USA

12. Departments of Medicine, Pharmacology, Pathology, Microbiology & Immunology; Vanderbilt University School of Medicine; Nashville Tennessee USA

Funder

The National Institutes of Health (NIH)

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.269/fullpdf

Reference40 articles.

1. Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues;Court;Xenobiotica,2012

2. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man;Bosma;J. Biol. Chem.,1994

3. Developmental aspects of human hepatic drug glucuronidation in young children and adults;Strassburg;Gut,2002

4. Pharmacogenetics of Gilbert's syndrome;Strassburg;Pharmacogenomics,2008

5. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype;Kadakol;Hum. Mutat.,2000

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world implementation of DPYD and UGT1A1 pharmacogenetic testing in a community‐based cancer center;Clinical and Translational Science;2024-01-26

2. Pharmacokinetics and pharmacodynamics of antibody-drug conjugates for the treatment of patients with breast cancer;Expert Opinion on Drug Metabolism & Toxicology;2024-01-12

3. Clinical Genetics and Referrals;Genomics in the Clinic;2024

4. Pharmacogenomics to support mental health medication therapy management: Clinical practice considerations and a conceptual framework to enhance patient care;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-12-03

5. Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin;Antimicrobial Agents and Chemotherapy;2023-11-15